BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16149121)

  • 1. Limited use of medicinal cannabis but for labeled indications after legalization.
    Erkens JA; Janse AF; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):821-2. PubMed ID: 16149121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medicinal use of cannabis in the Netherlands: towards a responsible pattern of use].
    de Jong FA
    Ned Tijdschr Geneeskd; 2009; 153():B23. PubMed ID: 19818189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use.
    Bifulco M; Pisanti S
    EMBO Rep; 2015 Feb; 16(2):130-2. PubMed ID: 25576303
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness].
    Killestein J; Bet PM; van Loenen AC; Polman CH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2374-8. PubMed ID: 15615271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical use of cannabis in the Netherlands.
    Gorter RW; Butorac M; Cobian EP; van der Sluis W
    Neurology; 2005 Mar; 64(5):917-9. PubMed ID: 15753439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal cannabis in oncology.
    Engels FK; de Jong FA; Mathijssen RH; Erkens JA; Herings RM; Verweij J
    Eur J Cancer; 2007 Dec; 43(18):2638-44. PubMed ID: 17976975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea.
    Hazekamp A; Bastola K; Rashidi H; Bender J; Verpoorte R
    J Ethnopharmacol; 2007 Aug; 113(1):85-90. PubMed ID: 17604926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?
    Martínez-Rodríguez JE; Munteis E; Carreño M; Blanco Y; Roquer J; Abanades S; Graus F; Saiz A
    J Neurol Sci; 2008 Oct; 273(1-2):103-7. PubMed ID: 18691726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
    Brunt TM; van Genugten M; Höner-Snoeken K; van de Velde MJ; Niesink RJ
    J Clin Psychopharmacol; 2014 Jun; 34(3):344-9. PubMed ID: 24747979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
    Russo EB; Guy GW; Robson PJ
    Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use as described by people with multiple sclerosis.
    Page SA; Verhoef MJ; Stebbins RA; Metz LM; Levy JC
    Can J Neurol Sci; 2003 Aug; 30(3):201-5. PubMed ID: 12945941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medicinal cannabis].
    Van der Meersch H; Verschuere AP; Bottriaux F
    J Pharm Belg; 2006; 61(3):69-78. PubMed ID: 17058879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can we learn from the Dutch cannabis coffeeshop system?
    MacCoun RJ
    Addiction; 2011 Nov; 106(11):1899-910. PubMed ID: 21906196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal cannabis in oncology practice: still a bridge too far?
    de Jong FA; Engels FK; Mathijssen RH; van Zuylen L; Verweij J; Peters RP; Sparreboom A
    J Clin Oncol; 2005 May; 23(13):2886-91. PubMed ID: 15860846
    [No Abstract]   [Full Text] [Related]  

  • 19. A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations.
    Lynch ME; Young J; Clark AJ
    J Pain Symptom Manage; 2006 Nov; 32(5):497-501. PubMed ID: 17085276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maryland legislator agrees with the legalization of medical marijuana.
    Morhaim D
    Md Med; 2011; 12(1):6; author reply 7, 21. PubMed ID: 21657168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.